Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 11-20 of 29 (Search time: 0.002 seconds).
Item hits:
Issue DateTitleAuthor(s)
15-Mar-2006Pilot study on low penetrance breast and colorectal cancer predisposition markers in LatviaIrmejs, Arvids; Miklasevics, Edvins; Boroschenko, Viktors; Gardovskis, Andris; Vanags, Andrejs; Melbarde-Gorkusa, Inga; Bitina, Marianna; Suchy, Janina; Gardovskis, Janis; Hereditary Cancer Research Department
15-Jun-2008Comment on the article Genetic contribution to all cancers : The first demonstration using the model of breast cancers from Poland stratified by age at diagnosis and tumour pathology by Lubinski et al., Breast Cancer Res Treat 2008 Apr 15Irmejs, Arvids; Miklaševics, Edvins; Štrumfa, Ilze; Gardovskis, Janis; Hereditary Cancer Research Department
30-Oct-2021Performance of contrast-enhanced ultrasound in thyroid nodules : Review of current state and future perspectivesRadzina, Maija; Ratniece, Madara; Putrins, Davis Simanis; Saule, Laura; Cantisani, Vito; Department of Radiology
Dec-2021Cancer microcell initiation and determinationSimsone, Zane; Freivalds, Tālivaldis; Bēma, Dina; Miķelsone, Indra; Patetko, Liene; Bērziņš, Juris; Harju, Līga; Buiķis, Indulis; Department of Human Physiology and Biochemistry
14-Apr-2012Challenges in the management of a patient with Cowden syndrome : Case report and literature reviewMelbarde-Gorkuša, Inga; Irmejs, Arvids; Berziņa, Dace; Štrumfa, Ilze; Aboliņš, Arnis; Gardovskis, Andris; Subatniece, Signe; Trofimovičs, Genadijs; Gardovskis, Janis; Miklaševičs, Edvins; Hereditary Cancer Research Department
1-Nov-2019The expression of the insulin receptor in gastric cancer correlates with the HER2 status and may have putative therapeutic implicationsHeckl, Steffen M.; Wiesener, Viva; Behrens, Hans Michael; Ulase, Dita; Krüger, Sandra; Röcken, Christoph; Department of Pathology
1-Sep-2021Darolutamide and health-related quality of life in patients with non-metastatic castration-resistant prostate cancer : An analysis of the phase III ARAMIS trialSmith, Matthew R.; Shore, Neal; Tammela, Teuvo L.; Ulys, Albertas; Vjaters, Egils; Polyakov, Sergey; Jievaltas, Mindaugas; Luz, Murilo; Alekseev, Boris; Kuss, Iris; Le Berre, Marie Aude; Mohamed, Ateesha F.; Odom, Dawn; Bartsch, Jennifer; Snapir, Amir; Sarapohja, Toni; Fizazi, Karim
Jun-2017Determination of cisplatin in human blood plasma and urine using liquid chromatography-mass spectrometry for oncological patient s with a variety of fatty tissue mass for prediction of toxicityGerina-Berzina, A.; Hasnere, S.; Kolesovs, A.; Umbrashko, S.; Muceniece, R.; Nakurte, I.; Institute of Anatomy and Anthropology
Jan-2023Effects of BRAF V600E and NRAS mutational status on the progression-free survival and clinicopathological characteristics of patients with melanomaZablocka, Tatjana; Kreismane, Madara; Pjanova, Dace; Isajevs, Sergejs
15-Feb-2008Hypoxia-selective targeting by the bioreductive prodrug AQ4N in patients with solid tumors : Results of a phase I studyAlbertella, Mark R.; Loadman, Paul M.; Jones, Philip H.; Phillips, Roger M.; Rampling, Roy; Burnet, Neil; Alcock, Chris; Anthoney, Alan; Vjaters, Egils; Dunk, Chris R.; Harris, Peter A.; Wong, Alvin; Lalani, Alshad S.; Twelves, Chris J.